Here are six points:
1. China has experienced an increase in spinal fusion surgeries due to better reimbursements and more patients opting for minimally invasive surgery.
2. An aging population and increasing incomes are driving more people with back issues to undergo spinal fusion surgery.
3. New technologies, such as improved implant materials, encourage more people to seek spinal fusion surgery.
4. The Chinese government and economic growth have facilitated spinal treatment for patients in rural areas by opening doors for better access to healthcare.
5. The market faces some obstacles in high surgery costs and alternative options, such as Intradiscal Electrothermal Annuloplasty.
6. Trauson, DePuy Synthes, Biomet, Medtronic, NuVasive, Stryker, Zimmer, Orthofix International, B. Braun Aesculap and Weigao Orthopaedic Device lead the market.
More articles on devices:
HSS conducts studies on a new modular partial wrist replacement: 5 takeaways
Wire stimulator technology provides chronic pain relief for San Antonio patients: 4 key points
Nextremity Solutions acquires Del Palma Orthopedics’ foot fusion technology: 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
